SCHEMBL13188836

SCHEMBL13188836

CN(CC(c1ccccc1)c1ccccc1)C(=O)[C@H](CCN)NCCNC(=O)c1ccc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.46
▸ OPRM1 P35372 2/20 0.45
▸ TMEM97 Q5BJF2 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ DRD2 P14416 2/20 0.41
▸ DRD3 P35462 2/20 0.41
▸ HDAC3 O15379 6/20 0.41
▸ HDAC1 Q13547 6/20 0.41
▸ HDAC4 P56524 5/20 0.41
▸ HDAC7 Q8WUI4 5/20 0.41
▸ HDAC2 Q92769 5/20 0.41
▸ HDAC10 Q969S8 5/20 0.41
▸ HDAC11 Q96DB2 5/20 0.41
▸ HDAC8 Q9BY41 5/20 0.41
▸ HDAC6 Q9UBN7 5/20 0.41
▸ HDAC9 Q9UKV0 5/20 0.41
▸ HDAC5 Q9UQL6 5/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ OPRD1 P41143 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13691772 0.89 OPRM1 (0.46) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13691769 0.88 OPRM1 (0.46) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13689401 0.87 OPRM1 (0.45) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13691793 0.85 NPC1 (0.47) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13691768 0.85 OPRM1 (0.45) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13691797 0.84 DRD2 (0.54) OPRM1TMEM97SIGMAR1DRD2DRD3
SCHEMBL13189116 0.84 UTS2R (0.39) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13689397 0.83 CXCR4 (0.43) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13691763 0.82 TMEM97 (0.46) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13691662 0.82 TMEM97 (0.47) NPC1TMEM97SIGMAR1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010096854-A1 METHODS OF MODULATING THE ACTIVITY OF THE MC3 AND/OR MC4 RECEPTORS AND TREATMENT OF CONDITIONS RELATED TO THESE RECEPTORS MIMETICA PTY LTD (AU) 2010-09-02 — — WO disclosed
WO-2009105824-A1 METHODS OF MODULATING THE ACTIVITY OF THE MC5 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR MIMETICA PTY LTD (AU) 2009-09-03 — — WO disclosed
Send feedback